New indications for direct thrombin inhibitors in the...

Details New indications for direct thrombin inhibitors in the... New indications for direct thrombin inhibitors in the...

A - Human Necessities

61

K

A61K 31/4439 (2006.01) A61K 31/397 (2006.01) A61K 31/4709 (2006.01) A61K 38/58 (2006.01) A61P 7/00 (2006.01) A61P 9/00 (2006.01)

Patent

CA 2657266

The invention relates to new indications for direct thrombin inhibitors such as dabigatran etexilate in the cardiovascular field.

La présente invention porte sur de nouvelles indications relatives aux inhibiteurs directs de la thrombine dans le domaine cardiovasculaire, tels que le dabigatran etexilate.

Affiliated with

Also associated with

Rating

New indications for direct thrombin inhibitors in the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with New indications for direct thrombin inhibitors in the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New indications for direct thrombin inhibitors in the... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2046465